Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Cash from Operations data on file, last reported at 18413000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 40.74% year-over-year to 18413000.0 in Q1 2026; TTM through Mar 2026 was 65408000.0, a 4.0% decrease from a year earlier, with the FY2025 full-year figure at 60078000.0, down 1.69% from the prior year.
• Cash from Operations for Q1 2026 stood at 18413000.0, down from 14461000.0 in the prior quarter.
• Over the last five years, Cash from Operations for TECX reached as high as 259000.0 in Q2 2023 and fell as low as 29106000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 16203529.41 across 5 years, with a median of 16415000.0 in 2022.
• Across the five-year window, Cash from Operations surged 99.11% in 2023 and tumbled 5066.8% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 23673000.0 in 2022, then surged by 50.76% to 11657000.0 in 2023, then sank by 44.3% to 16821000.0 in 2024, then increased by 14.03% to 14461000.0 in 2025, then fell by 27.33% to 18413000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 18413000.0 in Q1 2026, 14461000.0 in Q4 2025, and 17815000.0 in Q3 2025.